Google
Google
×
WHO global action plan to minimize poliovirus facility-associated risk after type- specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use: GAPIII. Thumbnail ...
polio vaccination, minimizing the risk of poliovirus reintroduction is critical. ... facility-associated risk after type-specific eradication of wild polioviruses and ... consistent with the goal of sequential cessation of OPV use after type-specific WPV.
In 2015, the WHO World Health Assembly endorsed The Global Action Plan to Minimize Poliovirus Facility–Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Poliovirus Vaccine Use pdf iconexternal icon(GAPIII), which provides a framework for containment.
Sep 27, 2019 · Facilities continuing to work with polioviruses after global eradication must ... Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use ... WHO global action plan to minimize poliovirus facility-associated risk ...
Sep 7, 2018 · Areas where monovalent oral poliovirus vaccine type 2 (mOPV2) has been used for ... The WHO Global Action Plan to minimize poliovirus facility–associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral poliovirus vaccine use (GAPIII) (7) defines the biorisk ...
Content WHO Global Action Plan: GAP III GAP III: timeline and global milestones Why ... With the Global Action Plan III (GAP III) the WHO defines a strategy to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses (WPV) and sequential cessation of routine OPV (oral polio vaccine) use.

Related searches

routine oral polio vaccination, minimizing the risk of poliovirus reintroduction is critical. In order ... Phase IIIa: Enhanced final containment of all wild polioviruses. ... poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of routine OPV use (GAPIII) has been made possible.
Wild poliovirus type 2 was declared eradicated by the Global Commission for the Certification of ... The WHO Global Action Plan to minimize poliovirus facility- associated risk after the type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use (GAPIII) was published in December. 2014 ...
and with it, the third Global Action Plan to minimize poliovirus ... ties* by the end of 2015 and of type 2 oral poliovirus vaccine ... cessation of the use of type- specific OPV to eliminate the risks ... Containment safeguards to minimize poliovirus facility-associated risks after type-specific eradication of wild polioviruses and.
to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use. 3.

Related searches